MeSH term
Frequency | Condition_Probility | Aged | 5 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Female | 7 | 0.0 |
Humans | 74 | 0.0 |
Base Sequence | 3 | 0.0 |
*Cell Cycle Proteins | 2 | 0.0 |
Cell Line | 8 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Cyclin D1/metabolism | 3 | 2.0 |
Molecular Sequence Data | 18 | 0.0 |
Phenotype | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 55 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 43 | 0.0 |
Transfection | 8 | 0.0 |
Antineoplastic Agents/pharmacology | 4 | 0.0 |
Antineoplastic Agents, Phytogenic/pharmacology | 2 | 2.0 |
Apoptosis | 4 | 0.0 |
Blotting, Western | 5 | 0.0 |
Cell Division | 2 | 0.0 |
Cell Nucleus/metabolism | 5 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Cysteine Endopeptidases/*metabolism | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Male | 8 | 0.0 |
Microscopy, Fluorescence | 5 | 0.0 |
Microtubules/metabolism | 2 | 1.0 |
Multienzyme Complexes/*metabolism | 2 | 1.0 |
Paclitaxel/pharmacology | 2 | 2.0 |
Peptidylprolyl Isomerase/*metabolism | 12 | 80.0 |
Phosphorylation | 46 | 0.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Protein Conformation | 13 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/*metabolism | 3 | 1.0 |
Serine/metabolism | 5 | 1.0 |
Signal Transduction | 7 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Binding Sites | 12 | 0.0 |
CDC2 Protein Kinase/metabolism | 2 | 1.0 |
Catalytic Domain | 3 | 1.0 |
DNA/metabolism | 2 | 0.0 |
DNA Damage | 3 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Glutathione Transferase/metabolism | 5 | 0.0 |
Immunoblotting | 3 | 0.0 |
Mitosis | 11 | 2.0 |
Mutation | 8 | 0.0 |
Plasmids/metabolism | 3 | 0.0 |
Protein Binding | 20 | 0.0 |
Protein Structure, Tertiary | 19 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 4 | 0.0 |
Amino Acid Sequence | 17 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Comparative Study | 4 | 0.0 |
Enzyme Inhibitors/pharmacology | 7 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Proline/chemistry | 2 | 4.0 |
Protein Interaction Mapping | 2 | 1.0 |
Protein Kinase Inhibitors | 2 | 1.0 |
Structure-Activity Relationship | 5 | 0.0 |
Cell Cycle | 8 | 0.0 |
Hela Cells | 17 | 0.0 |
Threonine/metabolism | 3 | 3.0 |
Time Factors | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Interphase | 3 | 1.0 |
Peptidylprolyl Isomerase/genetics/*metabolism | 6 | 100.0 |
Precipitin Tests | 3 | 0.0 |
RNA Polymerase II/chemistry/metabolism | 3 | 37.0 |
Amino Acid Substitution | 3 | 0.0 |
Kinetics | 4 | 0.0 |
Peptidylprolyl Isomerase/chemistry/genetics/*metabolism | 4 | 100.0 |
Phosphothreonine/metabolism | 5 | 11.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Peptidylprolyl Isomerase/physiology | 2 | 100.0 |
Cells, Cultured | 5 | 0.0 |
Mitosis/*physiology | 4 | 4.0 |
Substrate Specificity | 8 | 0.0 |
Adult | 4 | 0.0 |
Middle Aged | 5 | 0.0 |
Signal Transduction/*physiology | 3 | 0.0 |
*Transcription, Genetic | 2 | 0.0 |
Animals | 27 | 0.0 |
Catalytic Domain/genetics | 2 | 3.0 |
Xenopus | 3 | 0.0 |
Amino Acid Motifs | 9 | 1.0 |
*Nuclear Proteins | 3 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
Enzyme Activation | 3 | 0.0 |
In Vitro | 2 | 0.0 |
Mitosis/physiology | 4 | 4.0 |
Crystallography, X-Ray | 2 | 0.0 |
Magnetic Resonance Spectroscopy | 2 | 0.0 |
Models, Molecular | 6 | 0.0 |
Peptidylprolyl Isomerase/chemistry/*metabolism | 5 | 100.0 |
Phosphothreonine/*metabolism | 2 | 40.0 |
Tryptophan/*metabolism | 2 | 18.0 |
*Signal Transduction | 3 | 0.0 |
Isomerism | 2 | 0.0 |
Phosphoproteins/chemistry/metabolism | 2 | 8.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Naphthoquinones/pharmacology | 3 | 33.0 |
Phosphoserine/metabolism | 3 | 3.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
Alzheimer Disease/*metabolism | 3 | 1.0 |
Brain/*metabolism | 2 | 0.0 |
tau Proteins/*metabolism | 2 | 4.0 |
*Apoptosis | 3 | 0.0 |
Cell Survival | 2 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
Mice | 12 | 0.0 |
Catalysis | 3 | 0.0 |
*Cell Survival | 2 | 5.0 |
*Mitosis | 4 | 3.0 |
Proline/*metabolism | 3 | 18.0 |
Peptidylprolyl Isomerase/*chemistry/*metabolism | 2 | 100.0 |
Phosphoserine/*metabolism | 2 | 7.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 3 | 1.0 |
Thermodynamics | 2 | 0.0 |
Cell Cycle/*physiology | 3 | 1.0 |
Phosphoproteins/metabolism | 2 | 0.0 |
Subtilisin/metabolism | 2 | 50.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Peptidylprolyl Isomerase/metabolism | 4 | 50.0 |
Cell Cycle Proteins/metabolism | 2 | 0.0 |
Models, Biological | 4 | 0.0 |
Peptidylprolyl Isomerase/*physiology | 3 | 100.0 |
Protein p53/metabolism | 2 | 0.0 |
Tacrolimus Binding Proteins | 3 | 9.0 |
Hamsters | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
*Ubiquitin-Protein Ligases | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Phosphorylation/drug effects | 4 | 0.0 |
Epitope Mapping | 2 | 0.0 |
Cell Cycle Proteins/*metabolism | 2 | 0.0 |
Phosphoprotein Phosphatase/*metabolism | 3 | 3.0 |
cdc25 Phosphatase | 2 | 4.0 |
G2 Phase | 2 | 1.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
Peptidylprolyl Isomerase/*biosynthesis | 3 | 100.0 |
Prognosis | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
Carrier Proteins/chemistry | 2 | 5.0 |
Cell Cycle/physiology | 3 | 0.0 |
DNA-Binding Proteins/chemistry | 2 | 4.0 |
Peptidylprolyl Isomerase | 2 | 12.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Alzheimer Disease/*physiopathology | 2 | 10.0 |
Image Processing, Computer-Assisted | 2 | 0.0 |
Rats | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
tau Proteins/metabolism | 3 | 4.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Trans-Activation (Genetics) | 3 | 0.0 |
Apoptosis/physiology | 2 | 0.0 |
Peptidylprolyl Isomerase/antagonists & inhibitors/genetics/*metabolism | 2 | 100.0 |
Alzheimer Disease/*metabolism/pathology | 2 | 2.0 |
Gene Deletion | 3 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Neurons/metabolism/pathology | 2 | 2.0 |
Phosphoprotein Phosphatase/antagonists & inhibitors/metabolism | 2 | 22.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Fibroblasts | 2 | 0.0 |
*DNA Damage | 2 | 0.0 |
